4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-037932
CEO sold 9,650 shares at $18.50 ($178,564)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-16 | Sale : show line 1 in the form | −9,650 | $18.50 | $178,564 | 718,419 | D |
| Open-market sales · 9,650 sh · avg $18.50 · $178,564 | ||||||
Loading xslF345X05/form4.xml…